Medtronic (MDT) Gross Margin (2014 - 2026)

Medtronic has disclosed Gross Margin across 13 years of filings, most recently posting 63.83% for Q1 2026.

• Gross Margin for Q1 2026 came in at 63.83%, down 265.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 64.86% (down 41.0% YoY), and the FY2025 annual result was 65.32%, down 3.0% from the prior year.
• Gross Margin came in at 63.83% for Q1 2026 at Medtronic, down from 65.84% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 68.32% in Q1 2022 to a low of 63.83% in Q1 2026.
• The 5-year median for Gross Margin is 65.42% (2023), against an average of 65.68%.
• Across the five-year window, Gross Margin soared 203 bps in 2022 and plunged 312 bps in 2023, its largest moves.
• Medtronic's Gross Margin stood at 66.58% in 2022, then fell by 2 bps to 65.42% in 2023, then declined by 1 bps to 64.94% in 2024, then increased by 1 bps to 65.84% in 2025, then decreased by 3 bps to 63.83% in 2026.
• The last three Gross Margin figures came in at 63.83% (Q1 2026), 65.84% (Q4 2025), and 65.02% (Q3 2025), per Business Quant data.